Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012–2014)
We want to acknowledge the patients in this study for their participation particularly, and to the Spanish HIV HGM BioBank integrated into the Spanish AIDS Research Network (RIS) and collaborating centers for the generous gifs of clinical samples used in this work. Te HIV BioBank, integrated in the...
| Autores: | , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2019 |
| País: | España |
| Institución: | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| Repositorio: | Recercat. Dipósit de la Recerca de Catalunya |
| OAI Identifier: | oai:recercat.cat:20.500.12328/2637 |
| Acceso en línea: | http://hdl.handle.net/20.500.12328/2637 https://dx.doi.org/10.1038/s41598-018-37328-6 |
| Access Level: | acceso abierto |
| Palabra clave: | Diagnòstic de malalties infeccioses Epidemiologia vírica Hepatitis E VIH / VHC Diagnóstico de enfermedades infecciosas Epidemiología vírica Diagnosis of infectious diseases Viral epidemiology HIV / HCV 61 616.9 |
| Sumario: | We want to acknowledge the patients in this study for their participation particularly, and to the Spanish HIV HGM BioBank integrated into the Spanish AIDS Research Network (RIS) and collaborating centers for the generous gifs of clinical samples used in this work. Te HIV BioBank, integrated in the Spanish AIDS Research Network, is supported by the Institute of Health Carlos III, ISCIII, Spanish Health Ministry (Grant n° RD06/0006/0035 and RD12/0017/0037) as part of the State Plan for Scientifc and Technical Research and Innovation and co-fnanced by ISCIII- Sub-Directorate General for Research Assessment and Promotion and European Regional Development Fund (ERDF) and Foundation for Research and Prevention of AIDS in Spain (FIPSE). Tis study would not have been possible without the collaboration of all the patients, medical and nursing staf and data managers who have taken part in the project (See Text, Supplemental Digital Content 1, which show all collaborators). Te RIS Cohort (CoRIS) is funded by the ISCIII through the Spanish AIDS Research Network (RIS C03/173 and RD12/0017/0018) as part of the State Plan for Scientifc and Technical Research and Innovation and co-fnanced by ISCIII- Sub-Directorate General for Research Assessment and Promotion and European Regional Development Fund (ERDF). This study was supported by grants from Instituto de Salud Carlos III (ISCII; grant numbers grant numbers PI14/01094 and PI17/00657 to JB, PI14/01581, and PI17/00903to JGG, PI14CIII/00011, and PI17CIII/00003 to SR), Ministerio de Sanidad, Servicios Sociales e Igualdad (grant number EC11–241). Te RD16CIII/0002/0002, RD16/0025/0017, and RD16/0025/0018 projects also funded the study as part of the Plan Nacional R+D+I and co-funded by ISCIII- Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER). JB is an investigator from the Programa de Intensifcación de la Actividad Investigadora en el Sistema Nacional de Salud (I3SNS), Refs INT15/00079 and INT16/00100. |
|---|